Marshall Wace’s Nuvalent NUVL Stock Holding History

Marshall Wace’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$327K	Sell	3,194 -20,736	-87%	-$2.11M	﹤0.01%	2620
2025 Q4	$2.41M	Buy	+23,930	New	+$2.36M	﹤0.01%	1493
2025 Q3	–	Sell	-61,486	Closed	-$4.69M	–	3241
2025 Q2	$4.69M	Sell	61,486 -360,027	-85%	-$26.3M	0.01%	1167
2025 Q1	$29.9M	Buy	421,513 +60,473	+17%	+$4.73M	0.04%	402
2024 Q4	$28.3M	Buy	361,040 +219,336	+155%	+$20.5M	0.03%	440
2024 Q3	$14.5M	Buy	141,704 +57,623	+69%	+$4.78M	0.02%	619
2024 Q2	$6.38M	Buy	84,081 +77,229	+1,127%	+$5.49M	0.01%	905
2024 Q1	$515K	Sell	6,852 -248	-3%	-$19.7K	﹤0.01%	1909
2023 Q4	$522K	Sell	7,100 -34,247	-83%	-$2.12M	﹤0.01%	1705
2023 Q3	$1.9M	Buy	+41,347	New	+$1.84M	﹤0.01%	1244
2023 Q1	–	Sell	-60,581	Closed	-$1.8M	–	2971
2022 Q4	$1.8M	Sell	60,581 -21,430	-26%	-$598K	﹤0.01%	1783
2022 Q3	$1.59M	Buy	82,011 +54,630	+200%	+$914K	﹤0.01%	2157
2022 Q2	$372K	Buy	+27,381	New	+$290K	﹤0.01%	2939

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace's NUVL Position: Q1 2026 in Review

Marshall Wace reduced its Nuvalent (NUVL) stake by 87% in Q1 2026, selling an estimated $2.11M and leaving 3,194 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Marshall Wace first reported a position in NUVL in Q2 2022 and has held it in 13 quarters since. The position peaked at $29.9M in Q1 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Marshall Wace held 3,194 shares of Nuvalent worth $327K as of Q1 2026.
Marshall Wace sold 20,736 Nuvalent shares in Q1 2026, an estimated $2.11M.
Nuvalent made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2620 holding.
Marshall Wace first reported a position in Nuvalent in Q2 2022 and has held it in 13 quarters since.
Marshall Wace's Nuvalent position peaked at $29.9M in Q1 2025.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.